5 results for author:"Weiskopf K." in Literature citations
Results Customize
› Repeat search in UniProtKB (3)
| Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma. Edris B., Weiskopf K., Volkmer A.K., Volkmer J.P., Willingham S.B., Contreras-Trujillo H., Liu J., Majeti R., West R.B., Fletcher J.A. et al. Proc. Natl. Acad. Sci. U.S.A. 109:6656-6661(2012) · Mapped (5) |
| The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Willingham S.B., Volkmer J.P., Gentles A.J., Sahoo D., Dalerba P., Mitra S.S., Wang J., Contreras-Trujillo H., Martin R., Cohen J.D. et al. Proc. Natl. Acad. Sci. U.S.A. 109:6662-6667(2012) · Mapped (3) |
| Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer. Kohrt H.E., Houot R., Weiskopf K., Goldstein M.J., Scheeren F., Czerwinski D., Colevas A.D., Weng W.K., Clarke M.F., Carlson R.W. et al. J. Clin. Invest. 122:1066-1075(2012) · Mapped (5) |
| Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47. Chao M.P., Jaiswal S., Weissman-Tsukamoto R., Alizadeh A.A., Gentles A.J., Volkmer J., Weiskopf K., Willingham S.B., Raveh T., Park C.Y. et al. Sci Transl Med 2:63ra94-63ra94(2010) · Mapped (4) |
| Asterless is a scaffold for the onset of centriole assembly. Dzhindzhev N.S., Yu Q.D., Weiskopf K., Tzolovsky G., Cunha-Ferreira I., Riparbelli M., Rodrigues-Martins A., Bettencourt-Dias M., Callaini G., Glover D.M. |